Cargando…
Infarct tissue heterogeneity by contrast-enhanced MRI is a novel predictor of mortality in patients with coronary artery disease with reduced left ventricular systolic function
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106645/ http://dx.doi.org/10.1186/1532-429X-13-S1-O7 |
| _version_ | 1782204869661163520 |
|---|---|
| author | Watanabe, Eri Coelho-Filho, Otavio Rizzi Mongeon, François-Pierre Jerosch-Herold, Michael Abdullah, Shuaib M Blankstein, Ron Hatabu, Hiroto Mandry, Damien Heydari, Bobby van der Geest, Rob J Kwong, Raymond Y |
| author_facet | Watanabe, Eri Coelho-Filho, Otavio Rizzi Mongeon, François-Pierre Jerosch-Herold, Michael Abdullah, Shuaib M Blankstein, Ron Hatabu, Hiroto Mandry, Damien Heydari, Bobby van der Geest, Rob J Kwong, Raymond Y |
| author_sort | Watanabe, Eri |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-3106645 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2011 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-31066452011-06-03 Infarct tissue heterogeneity by contrast-enhanced MRI is a novel predictor of mortality in patients with coronary artery disease with reduced left ventricular systolic function Watanabe, Eri Coelho-Filho, Otavio Rizzi Mongeon, François-Pierre Jerosch-Herold, Michael Abdullah, Shuaib M Blankstein, Ron Hatabu, Hiroto Mandry, Damien Heydari, Bobby van der Geest, Rob J Kwong, Raymond Y J Cardiovasc Magn Reson Oral Presentation BioMed Central 2011-02-02 /pmc/articles/PMC3106645/ http://dx.doi.org/10.1186/1532-429X-13-S1-O7 Text en Copyright ©2011 Watanabe et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Oral Presentation Watanabe, Eri Coelho-Filho, Otavio Rizzi Mongeon, François-Pierre Jerosch-Herold, Michael Abdullah, Shuaib M Blankstein, Ron Hatabu, Hiroto Mandry, Damien Heydari, Bobby van der Geest, Rob J Kwong, Raymond Y Infarct tissue heterogeneity by contrast-enhanced MRI is a novel predictor of mortality in patients with coronary artery disease with reduced left ventricular systolic function |
| title | Infarct tissue heterogeneity by contrast-enhanced MRI is a novel predictor of mortality in patients with coronary artery disease with reduced left ventricular systolic function |
| title_full | Infarct tissue heterogeneity by contrast-enhanced MRI is a novel predictor of mortality in patients with coronary artery disease with reduced left ventricular systolic function |
| title_fullStr | Infarct tissue heterogeneity by contrast-enhanced MRI is a novel predictor of mortality in patients with coronary artery disease with reduced left ventricular systolic function |
| title_full_unstemmed | Infarct tissue heterogeneity by contrast-enhanced MRI is a novel predictor of mortality in patients with coronary artery disease with reduced left ventricular systolic function |
| title_short | Infarct tissue heterogeneity by contrast-enhanced MRI is a novel predictor of mortality in patients with coronary artery disease with reduced left ventricular systolic function |
| title_sort | infarct tissue heterogeneity by contrast-enhanced mri is a novel predictor of mortality in patients with coronary artery disease with reduced left ventricular systolic function |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106645/ http://dx.doi.org/10.1186/1532-429X-13-S1-O7 |
| work_keys_str_mv | AT watanabeeri infarcttissueheterogeneitybycontrastenhancedmriisanovelpredictorofmortalityinpatientswithcoronaryarterydiseasewithreducedleftventricularsystolicfunction AT coelhofilhootaviorizzi infarcttissueheterogeneitybycontrastenhancedmriisanovelpredictorofmortalityinpatientswithcoronaryarterydiseasewithreducedleftventricularsystolicfunction AT mongeonfrancoispierre infarcttissueheterogeneitybycontrastenhancedmriisanovelpredictorofmortalityinpatientswithcoronaryarterydiseasewithreducedleftventricularsystolicfunction AT jeroschheroldmichael infarcttissueheterogeneitybycontrastenhancedmriisanovelpredictorofmortalityinpatientswithcoronaryarterydiseasewithreducedleftventricularsystolicfunction AT abdullahshuaibm infarcttissueheterogeneitybycontrastenhancedmriisanovelpredictorofmortalityinpatientswithcoronaryarterydiseasewithreducedleftventricularsystolicfunction AT blanksteinron infarcttissueheterogeneitybycontrastenhancedmriisanovelpredictorofmortalityinpatientswithcoronaryarterydiseasewithreducedleftventricularsystolicfunction AT hatabuhiroto infarcttissueheterogeneitybycontrastenhancedmriisanovelpredictorofmortalityinpatientswithcoronaryarterydiseasewithreducedleftventricularsystolicfunction AT mandrydamien infarcttissueheterogeneitybycontrastenhancedmriisanovelpredictorofmortalityinpatientswithcoronaryarterydiseasewithreducedleftventricularsystolicfunction AT heydaribobby infarcttissueheterogeneitybycontrastenhancedmriisanovelpredictorofmortalityinpatientswithcoronaryarterydiseasewithreducedleftventricularsystolicfunction AT vandergeestrobj infarcttissueheterogeneitybycontrastenhancedmriisanovelpredictorofmortalityinpatientswithcoronaryarterydiseasewithreducedleftventricularsystolicfunction AT kwongraymondy infarcttissueheterogeneitybycontrastenhancedmriisanovelpredictorofmortalityinpatientswithcoronaryarterydiseasewithreducedleftventricularsystolicfunction |